Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Antitumor baccatin derivatives from Tanabe Seiyaku

June 21, 1996

DX-8951f enters phase I

June 21, 1996

Camptosar approved in U.S.

June 21, 1996

Pierre Fabre reveals cancer treatment agents

June 21, 1996

Bristol-Myers Squibb isolates and synthesizes hayumicin antitumor antibiotics

June 21, 1996

RPR granted rights to Gliadel

June 21, 1996

Grelan to codevelop BioNumerik's BNP-7787

June 14, 1996

Betamipron offers nephrotoxicity protection

June 14, 1996

XR-9051: MDR-reversing agent

June 14, 1996

Fujisawa reveals FR-177391, agent for cachexia in cancer patients

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...